menu-iconMore mobile-close-icon
Skip Navigation
Skip Navigation
Home
Browse Guidelines
Expert Commentaries
Guideline Syntheses
Guideline Matrix
Guideline Resources
Compare Guidelines
Frequently Asked Questions
Submit Guidelines
About
myNGC

Announcements

April 02, 2012

Health Awareness Topics - April 2012



NGC Spotlight


Visit the updated Hospital-Acquired Conditions page for evidence-based resources available on the NGC Web site to assist users in the prevention of the CMS-identified hospital-acquired conditions.

Conference News


The Guidelines International Network (G-I-N) Conference 2012, will be held August 22-25, 2012 in Berlin, Germany. Registration External Web Site Policy is now open.

U.S. Food and Drug Administration (FDA) Advisory


  • March 28, 2012: Celexa (citalopram hydrobromide) External Web Site Policy: FDA is clarifying dosing and warning recommendations for the antidepressant Celexa (citalopram hydrobromide; also available in generic form). The revised drug label describes lower doses that should be used in patients over 60 years of age.

NGC's Sister Resources